Insider trades
Secora Michael, CFO of Recursion Pharmaceuticals RXRX, has filed 0 purchases and 39 sales on the open market. The latest trade was on 24/11/15.
Secora Michael
CFO
- First filing
- 23/02/03
- Trades
- 126 trades
- Buys / sales
- 0 / 39
- 12-month net buying
- No record
- Last trade
- 24/11/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RXRX | Open-market sale10b5-1 plan | 24/11/12–24/11/13 | 24/11/14 | 30,000 sh2 trades | $7.65avg. | $229,500 | −2.0% |
RXRX | Open-market sale10b5-1 plan | 24/10/08–24/10/09 | 24/10/10 | 30,000 sh2 trades | $6.34avg. | $190,200 | −2.0% |
RXRX | Open-market sale10b5-1 plan | 24/09/10–24/09/11 | 24/09/12 | 30,000 sh2 trades | $6.25avg. | $187,350 | −2.1% |
RXRX | Open-market sale10b5-1 plan | 24/08/13–24/08/14 | 24/08/15 | 30,000 sh2 trades | $6.35avg. | $190,500 | −2.2% |
RXRX | Open-market sale10b5-1 plan | 24/07/09–24/07/10 | 24/07/11 | 30,000 sh2 trades | $7.28avg. | $218,400 | −2.2% |
RXRX | Open-market sale10b5-1 plan | 24/06/13–24/06/14 | 24/06/17 | 30,000 sh2 trades | $9.30avg. | $278,850 | −2.3% |
RXRX | Open-market sale10b5-1 plan | 24/04/16–24/04/17 | 24/04/18 | 48,124 sh2 trades | $7.63avg. | $367,029.92 | −3.8% |
RXRX | Open-market sale10b5-1 plan | 24/03/12–24/03/13 | 24/03/14 | 50,000 sh2 trades | $10.75avg. | $537,250 | −4.0% |
RXRX | Open-market sale10b5-1 plan | 24/02/13–24/02/14 | 24/02/15 | 50,000 sh3 trades | $10.16avg. | $507,836.85 | −4.0% |
RXRX | Open-market sale10b5-1 plan | 24/01/16–24/01/17 | 24/01/18 | 50,000 sh2 trades | $10.35avg. | $517,500 | −4.8% |
RXRX | Open-market sale10b5-1 plan | 23/12/12–23/12/13 | 23/12/14 | 50,000 sh2 trades | $7.49avg. | $374,500 | −5.0% |
RXRX | Open-market sale10b5-1 plan | 23/11/14–23/11/15 | 23/11/16 | 50,000 sh3 trades | $6.82avg. | $340,989 | −5.1% |
RXRX | Open-market sale10b5-1 plan | 23/10/10–23/10/11 | 23/10/12 | 50,000 sh2 trades | $6.96avg. | $348,000 | −5.2% |
RXRX | Open-market sale10b5-1 plan | 23/09/12–23/09/13 | 23/09/14 | 50,000 sh2 trades | $8.56avg. | $428,000 | −5.3% |
RXRX | Open-market sale10b5-1 plan | 23/08/15–23/08/16 | 23/08/17 | 50,000 sh2 trades | $9.09avg. | $454,250 | −5.5% |
RXRX | Open-market sale10b5-1 plan | 23/07/18–23/07/19 | 23/07/19 | 50,000 sh5 trades | $14.58avg. | $729,033.76 | −5.6% |
RXRX | Open-market sale10b5-1 plan | 23/06/13–23/06/14 | 23/06/15 | 50,000 sh2 trades | $10.00avg. | $500,000 | −5.8% |